Subpart H - PAYMENT FOR END-STAGE RENAL DISEASE (ESRD) SERVICES
- Section 413.170 - Scope
- Section 413.171 - Definitions
- Section 413.172 - Principles of prospective payment
- Section 413.174 - Prospective rates for hospital-based and independent ESRD facilities
- Section 413.176 - Amount of payments
- Section 413.177 - Quality incentive program payment
- Section 413.178 - ESRD quality incentive program
- Section 413.180 - Procedures for requesting exceptions to payment rates
- Section 413.182 - Criteria for approval of exception requests
- Section 413.184 - Payment exception: Pediatric patient mix
- Section 413.186 - Payment exception: Self-dialysis training costs in pediatric facilities
- Section 413.194 - Appeals
- Section 413.195 - Limitation on Review
- Section 413.196 - Notification of changes in rate-setting methodologies and payment rates
- Section 413.198 - Recordkeeping and cost reporting requirements for outpatient maintenance dialysis
- Section 413.200 - Reserved
- Section 413.202 - Organ procurement organization (OPO) cost for kidneys sent to foreign countries or transplanted in patients other than Medicare beneficiaries
- Section 413.203 - Transplant center costs for organs sent to foreign countries or transplanted in patients other than Medicare beneficiaries
- Section 413.210 - Conditions for payment under the end-stage renal disease (ESRD) prospective payment system
- Section 413.215 - Basis of payment
- Section 413.217 - Items and services included in the ESRD prospective payment system
- Section 413.220 - Methodology for calculating the per-treatment base rate under the ESRD prospective payment system effective January 1, 2011
- Section 413.230 - Determining the per treatment payment amount
- Section 413.231 - Adjustment for wages
- Section 413.232 - Low-volume adjustment
- Section 413.233 - Rural facility adjustment
- Section 413.234 - [Effective 1/1/2025] Drug designation process
- Section 413.234 - [Effective until 1/1/2025] Drug designation process
- Section 413.235 - Patient-level adjustments
- Section 413.236 - Transitional add-on payment adjustment for new and innovative equipment and supplies
- Section 413.237 - Outliers
- Section 413.239 - Transition period
- Section 413.241 - Pharmacy arrangements